{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T12:15:36Z","timestamp":1780488936482,"version":"3.54.1"},"reference-count":39,"publisher":"SAGE Publications","issue":"2","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Substance Abuse"],"published-print":{"date-parts":[[2019,4]]},"abstract":"<jats:p>\n                    <jats:italic toggle=\"yes\">Background:<\/jats:italic>\n                    Patients taking methadone for opioid use disorder may desire transition to buprenorphine for a number of reasons. However, the current recommended approach for this transition generally takes weeks to months as an outpatient, causing considerable discomfort to the patient and a heightened risk of relapse during the transition period.\n                    <jats:italic toggle=\"yes\">Case:<\/jats:italic>\n                    We describe the case of a patient on methadone maintenance who was rapidly transitioned to buprenorphine because of her desire to not return to her methadone clinic. In order to rapidly transition the patient from methadone to buprenorphine, naltrexone was administered to precipitate acute opioid withdrawal, which was followed soon after by buprenorphine induction.\n                    <jats:italic toggle=\"yes\">Discussion:<\/jats:italic>\n                    Rapid transition from methadone maintenance to buprenorphine can be accomplished in inpatients by precipitating acute withdrawal with naltrexone, providing an effective alternative for patients who cannot tolerate the typical protracted methadone taper required prior to buprenorphine induction as an outpatient.\n                  <\/jats:p>","DOI":"10.1080\/08897077.2019.1573776","type":"journal-article","created":{"date-parts":[[2019,3,19]],"date-time":"2019-03-19T14:58:26Z","timestamp":1553007506000},"page":"140-145","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":19,"title":["Rapid Transition from Methadone to Buprenorphine Using Naltrexone-Induced Withdrawal: A Case Report"],"prefix":"10.1177","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2901-8004","authenticated-orcid":false,"given":"Heather Burrell","family":"Ward","sequence":"first","affiliation":[{"name":"Psychiatry Residency Program, Harvard Medical School, Brigham and Women's Hospital, Boston, Massachusetts, USA;"},{"name":"Harvard Medical School, Boston, Massachusetts, USA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8963-5701","authenticated-orcid":false,"given":"Brian S.","family":"Barnett","sequence":"additional","affiliation":[{"name":"Harvard Medical School, Boston, Massachusetts, USA;"},{"name":"Addiction Psychiatry Fellowship Program, Partners Healthcare, Boston, Massachusetts, USA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5659-6147","authenticated-orcid":false,"given":"Joji","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Harvard Medical School, Boston, Massachusetts, USA;"},{"name":"Department of Psychiatry, Brigham and Women's Hospital, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2019,4,1]]},"reference":[{"key":"e_1_3_1_2_2","unstructured":"Casadonte PP. Transfer from methadone to buprenorphine. 2013."},{"key":"e_1_3_1_3_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10840-009-9465-9"},{"key":"e_1_3_1_4_2","volume-title":"Substance abuse treatment: Group therapy","author":"Substance Abuse and Mental Health Services Administration (SAMHSA)","year":"2005","unstructured":"Substance Abuse and Mental Health Services Administration (SAMHSA). Substance abuse treatment: Group therapy. Rockville, MD: Substance Abuse and Mental Health Services Administration;2005."},{"key":"e_1_3_1_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0376-8716(03)00071-1"},{"key":"e_1_3_1_6_2","doi-asserted-by":"publisher","DOI":"10.1080\/00952990.2017.1363218"},{"key":"e_1_3_1_7_2","doi-asserted-by":"publisher","DOI":"10.1080\/13556219772732"},{"key":"e_1_3_1_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1521-0391.1997.tb00559.x"},{"key":"e_1_3_1_9_2","doi-asserted-by":"publisher","DOI":"10.2174\/1874473711205010052"},{"key":"e_1_3_1_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2015.05.004"},{"key":"e_1_3_1_11_2","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0b013e3181add3f5"},{"key":"e_1_3_1_12_2","volume-title":"Medications for Opioid Use Disorder","author":"Substance Abuse and Mental Health Services Administration (SAMHSA)","year":"2018","unstructured":"Substance Abuse and Mental Health Services Administration (SAMHSA). Medications for Opioid Use Disorder. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2018."},{"key":"e_1_3_1_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2007.04.006"},{"key":"e_1_3_1_14_2","volume-title":"Clinical Guidelines for the Use of Buprenorphine in the Treatment of Opioid Addiction","author":"Substance Abuse and Mental Health Services Administration (SAMHSA)","year":"2004","unstructured":"Substance Abuse and Mental Health Services Administration (SAMHSA). Clinical Guidelines for the Use of Buprenorphine in the Treatment of Opioid Addiction. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2004."},{"key":"e_1_3_1_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0376-8716(99)00084-8"},{"key":"e_1_3_1_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2005.11.007"},{"key":"e_1_3_1_17_2","doi-asserted-by":"publisher","DOI":"10.3109\/00952997709007010"},{"key":"e_1_3_1_18_2","doi-asserted-by":"publisher","DOI":"10.1151\/ascp074145"},{"key":"e_1_3_1_19_2","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.64.12_Suppl.44"},{"key":"e_1_3_1_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2005.01.013"},{"key":"e_1_3_1_21_2","doi-asserted-by":"publisher","DOI":"10.1080\/13556210500123126"},{"key":"e_1_3_1_22_2","first-page":"56","article-title":"Buprenorphine rescue from naltrexone-induced opioid withdrawal during relatively rapid detoxification from high-dose methadone: a novel approach","volume":"5","author":"Urban V","year":"2008","unstructured":"Urban V, , Sullivan R. Buprenorphine rescue from naltrexone-induced opioid withdrawal during relatively rapid detoxification from high-dose methadone: a novel approach. Psychiatry. 2008;5:56\u201358.","journal-title":"Psychiatry"},{"key":"e_1_3_1_23_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.294.8.903"},{"key":"e_1_3_1_24_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.279.3.229"},{"key":"e_1_3_1_25_2","doi-asserted-by":"publisher","DOI":"10.1517\/14740338.6.3.289"},{"key":"e_1_3_1_26_2","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.2006.100180"},{"key":"e_1_3_1_27_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2010.10060879"},{"key":"e_1_3_1_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2007.01.040"},{"key":"e_1_3_1_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0376-8716(03)00060-7"},{"key":"e_1_3_1_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2004.11.055"},{"key":"e_1_3_1_31_2","doi-asserted-by":"publisher","DOI":"10.1097\/JPN.0000000000000044"},{"key":"e_1_3_1_32_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.167.22.2469"},{"key":"e_1_3_1_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2006.11.003"},{"key":"e_1_3_1_34_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1465-3362.2009.00127.x"},{"key":"e_1_3_1_35_2","doi-asserted-by":"publisher","DOI":"10.1111\/ajad.12161"},{"key":"e_1_3_1_36_2","doi-asserted-by":"publisher","DOI":"10.1080\/02791072.2003.10400007"},{"key":"e_1_3_1_37_2","doi-asserted-by":"publisher","DOI":"10.1177\/0960327112450901"},{"key":"e_1_3_1_38_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13722-017-0074-0"},{"key":"e_1_3_1_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2016.06.024"},{"key":"e_1_3_1_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2015.12.035"}],"container-title":["Substance Abuse"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1080\/08897077.2019.1573776","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1080\/08897077.2019.1573776","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1080\/08897077.2019.1573776","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T11:41:43Z","timestamp":1780486903000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1080\/08897077.2019.1573776"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["10.1080\/08897077.2019.1573776"],"URL":"https:\/\/doi.org\/10.1080\/08897077.2019.1573776","relation":{},"ISSN":["0889-7077","1547-0164"],"issn-type":[{"value":"0889-7077","type":"print"},{"value":"1547-0164","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4]]}}}